Key result
Age under 85 and transfemoral approach each linked to ~63% lower mortality after TAVI.
Why the study?
Data on long-term survival after TAVI in Japan were limited, and regional disparities remained.
Cohort (n=446)
Effect estimate: HR 0.37 (95% CI 0.20-0.69)
p-value: p=0.002
In a Japanese regional cohort, TAVI demonstrated a 7-year survival rate of 54.4%, with age <85 years and transfemoral approach predicting better outcomes, while renal, cerebrovascular, and rheumatologic diseases predicted poorer long-term survival.
May inform TAVI risk discussions; leaves open prospective validation of age and access associations.
Transcatheter aortic valve implantation (TAVI) in patients with severe aortic valve stenosis (AS) is becoming an established technique. However, data on long-term survival in Japan are limited and regional disparities remain. We aimed to evaluate long-term survival after TAVI using the Nara Kokuho Database (KDB). Patients who underwent TAVI between July 2014 and March 2023 were enrolled. The study outcomes were to evaluate survival rates after TAVI over 1-7 years and predict long-term prognostic factors using Kaplan-Meier analysis and Cox proportional hazards model. Of 446 consecutive patients, 284 were female participants (63.7%). The mean age was 84.1 ± 4.3 years. The overall survival rates were 95.1-54.4% over 1-7 years. Cox proportional hazards model analysis revealed that younger age (< 85 years, hazard ratio [HR], 0.38; 95% confidence interval [CI], 0.20-0.69; p = 0.002) and transfemoral approach (HR, 0.37; 95% CI 0.17-0.78; p = 0.009) were predictive factors. However, renal disease (HR, 2.02; 95% CI 1.08-3.77; p = 0.03), cerebrovascular disease (HR, 2.02; 95% CI 1.13-3.63; p = 0.02), and rheumatologic disease (HR, 2.71; 95% CI 1.19-6.18; p = 0.02) were poor long-term prognostic factors. This study measured the long-term survival after TAVI using Nara KDB data, identifying factors that might serve as predictive indicators.
No takes yet. Share an insight, caveat, or question.
Takemoto et al. (2025) conducted a cohort in Severe aortic valve stenosis (n=446). Transcatheter aortic valve implantation (TAVI) was evaluated on Long-term survival (prognostic factor: age < 85 years) (HR 0.37, 95% CI 0.20-0.69, p=0.002). In patients with severe aortic valve stenosis undergoing TAVI, overall survival was 54.4% at 7 years, with age <85 years (HR 0.37) and transfemoral approach (HR 0.37) identified as significant favorable prognostic factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: